Cargando…
Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification
A proinflammatory cytokine IL-32 acts as an intracellular mediator. IL-32α interacts with many intracellular molecules, but there are no reports of interaction with a transcriptional repressor BCL6. In this study, we showed that PMA induces an interaction between IL-32α, PKCε, and BCL6, forming a tr...
Autores principales: | Park, Yun Sun, Kang, Jeong-Woo, Lee, Dong Hun, Kim, Man Sub, Bak, Yesol, Yang, Young, Lee, Hee Gu, Hong, JinTae, Yoon, Do-Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226720/ https://www.ncbi.nlm.nih.gov/pubmed/25245533 |
Ejemplares similares
-
IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer
por: Bak, Yesol, et al.
Publicado: (2016) -
IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1
por: Kim, Man Sub, et al.
Publicado: (2015) -
Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer
por: Pham, Thu-Huyen, et al.
Publicado: (2019) -
SUMO modification in apoptosis
por: Li, Peiyao, et al.
Publicado: (2020) -
Ubiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
por: Cai, Qiliang, et al.
Publicado: (2010)